CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.49
-0.01 (-0.18%)
Aug 14, 2025, 11:30 AM - Market open
CureVac Market Cap
CureVac has a market cap or net worth of $1.24 billion as of August 14, 2025. Its market cap has increased by 50.18% in one year.
Market Cap
1.24B
Enterprise Value
800.58M
1-Year Change
50.18%
Ranking
Category
Stock Price
$5.49
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.24B, a decrease of -87.43%. That is a compound annual growth rate of -33.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.24B | 61.91% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |